Viewing Study NCT01579851


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-30 @ 10:41 PM
Study NCT ID: NCT01579851
Status: COMPLETED
Last Update Posted: 2017-05-22
First Post: 2012-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recovery After Sugammadex(Propofol vs Sevoflurane)
Sponsor: Hopital Foch
Organization:

Study Overview

Official Title: Recovery After Sugammadex(TIVA Using Propofol vs Inhalation Anesthesia Using Sevoflurane)
Status: COMPLETED
Status Verified Date: 2017-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Sugammadex2
Brief Summary: Sugammadex is used to reverse of a neuro-muscular block deep. It has been reported that its administration could induce signs of recovery despite continuation of anesthetic drugs. The goal of the present study is to look is the arte of this event is different according to the primary anesthetic agent used.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2010-023943-13 EUDRACT_NUMBER None View